New Stricter FDA Limits Placed On Use of J & J COVID-19 Vaccine for Certain Individuals

Want Instant Blog Updates?

Get an email whenever we publish a new article!
PLEASE NOTE:
This subscribe option does not work in some browsers with ad blockers. To ensure your sign up request goes through, use the Google Chrome browser when confirming your subscription from your inbox.

May 15, 2022

On May 5, 2022 the “U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine“.

“The FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen COVID-19 Vaccine, warrants limiting the authorized use of the vaccine

Access the complete Press release here


 

We've got a lot to talk about

Read More